# RenovoRx, Inc. – FDA Inspection, Apr 4, 2022

Source: https://www.keypedia.com/records/fda_inspections/renovorx-inc/a3744e11-0422-4793-b1f6-94995dbbc6b9
Source feed: FDA_Inspections

> FDA inspection 1166306 of RenovoRx, Inc., April 04, 2022. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 803. 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1166306
- Company Name: RenovoRx, Inc.
- Inspection Date: 2022-04-04
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Compliance: Devices
- Product Type: Devices
- Center: Medical Devices & Rad Health
- Office Name: Center for Devices and Radiological Health
- Citation Count: 1

## Related Documents

- FDA Inspection 1324452 - 2026-06-16
- FDA Inspection 978263 - 2016-05-18

Company: https://www.keypedia.com/companies/renovorx-inc/53ed9d73-0643-4791-8e37-cd5a04c834fd

Office: https://www.keypedia.com/offices/center-for-devices-and-radiological-health/9d89aff6-e435-4764-87be-f58c01aca7f7